HCA Healthcare, Inc. $HCA is Abrams Bison Investments LLC’s 8th Largest Position

Abrams Bison Investments LLC decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 33.3% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 170,000 shares of the company’s stock after selling 85,000 shares during the quarter. HCA Healthcare comprises about 5.7% of Abrams Bison Investments LLC’s portfolio, making the stock its 8th largest holding. Abrams Bison Investments LLC owned approximately 0.07% of HCA Healthcare worth $72,454,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Cerity Partners LLC increased its position in HCA Healthcare by 13.1% in the third quarter. Cerity Partners LLC now owns 43,920 shares of the company’s stock worth $18,719,000 after purchasing an additional 5,092 shares during the last quarter. Swiss National Bank raised its position in shares of HCA Healthcare by 4.3% during the 2nd quarter. Swiss National Bank now owns 558,900 shares of the company’s stock valued at $214,115,000 after buying an additional 23,100 shares in the last quarter. National Pension Service grew its position in HCA Healthcare by 2.9% in the third quarter. National Pension Service now owns 626,585 shares of the company’s stock worth $267,051,000 after acquiring an additional 17,531 shares in the last quarter. Savant Capital LLC raised its position in HCA Healthcare by 37.7% during the third quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock valued at $1,938,000 after purchasing an additional 1,246 shares during the period. Finally, Sector Gamma AS boosted its holdings in shares of HCA Healthcare by 36.0% in the 3rd quarter. Sector Gamma AS now owns 10,883 shares of the company’s stock worth $4,638,000 after purchasing an additional 2,883 shares during the period. Institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on HCA shares. Argus raised their price target on HCA Healthcare from $530.00 to $560.00 and gave the stock a “buy” rating in a research report on Friday, February 6th. Truist Financial raised their target price on shares of HCA Healthcare from $520.00 to $546.00 and gave the stock a “buy” rating in a report on Wednesday, January 28th. UBS Group increased their price objective on shares of HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a research report on Monday, February 23rd. Barclays boosted their target price on HCA Healthcare from $494.00 to $551.00 and gave the company an “overweight” rating in a research report on Wednesday, January 28th. Finally, KeyCorp set a $503.00 price target on HCA Healthcare in a research note on Wednesday, January 28th. Sixteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and an average target price of $537.73.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $533.39 on Friday. The stock has a market cap of $119.28 billion, a price-to-earnings ratio of 18.79, a price-to-earnings-growth ratio of 1.64 and a beta of 1.34. The firm has a 50-day moving average of $507.05 and a two-hundred day moving average of $470.03. HCA Healthcare, Inc. has a 1 year low of $313.21 and a 1 year high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. The firm had revenue of $19.51 billion during the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.HCA Healthcare’s quarterly revenue was up 6.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be issued a $0.78 dividend. The ex-dividend date is Tuesday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 10.15%.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total value of $2,020,000.00. Following the completion of the transaction, the senior vice president owned 44,379 shares of the company’s stock, valued at $22,411,395. The trade was a 8.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Michael S. Cuffe sold 1,500 shares of the stock in a transaction on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total value of $747,135.00. Following the sale, the executive vice president directly owned 30,003 shares in the company, valued at $14,944,194.27. This trade represents a 4.76% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 15,214 shares of company stock valued at $7,797,595 in the last 90 days. Insiders own 1.30% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.